Boston Scientific gets FDA clearance for system for removing clots from arteries

By Elaine Rigoli

Tampa, Fla., May 31 - Boston Scientific Corp. has received clearance from the Food and Drug Administration to market its Rio Aspiration catheter, indicated for use in the removal of thrombi, or clots, from vessels throughout the body.

Clots can restrict or block blood flow in an artery, creating difficulty or risk to a patient when undergoing intravascular procedures.

The Rio Aspiration Catheter can be used with other interventional devices, such as those used to place stents, to open blockages caused by clots in the target area within a vessel, according to a news release.

Boston Scientific, based in Natick, Mass., develops medical devices for a range of interventional medical specialties.

© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.